We are live on
!
Find out more
PDLI
PDL BioPharma, Inc.
PDLI
PDLI
Delisted
PDLI was delisted on the 30th of December, 2020.
133 hedge funds and large institutions have $260M invested in PDL BioPharma, Inc. in 2020 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 30 increasing their positions, 58 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
152% more call options, than puts
Call options by funds: $252K | Put options by funds: $100K
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
11% less funds holding
Funds holding: 150 → 133 (-17)
18% less capital invested
Capital invested by funds: $318M → $260M (-$58M)
48% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 58
50% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 30
Holders
133
Holders Change
-17
Holders Change %
-11.33%
% of All Funds
2.93%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
15
Increased
30
Reduced
58
Closed
30
Calls
$252K
Puts
$100K
Net Calls
+$152K
Net Calls Change
-$157K
Top Buyers
Top Sellers
| 1 |
ECM
Engine Capital Management
New York
|
-$9.79M |
| 2 |
NM
Newtyn Management
New York
|
-$4.87M |
| 3 |
WG
Winton Group
London,
United Kingdom
|
-$4.21M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$2.76M |
| 5 |
BlackRock
New York
|
-$2.64M |
